Subira Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Subira Pharmaceuticals Private Limited

Subira Pharmaceuticals Private Limited, a active private limited company, was established on 08 October 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233MH2013PTC328984. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Vishal Khanna (Director), Kavita Khanna (Director). It holds ₹5.00 M open charges and ₹2.21 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2013PTC328984

  • Registration Number

    328984

  • Incorporation Date

    08 October 2013

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.00 M
  • Satisfied Charges ₹ 2.21 Cr
  • Revenue Growth **** 17.60%
  • Profit Growth **** -24.26%
  • Ebitda **** -35.91%
  • Net Worth 21.12%
  • Total Assets **** 25.58%
Company report

Subira Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Subira Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Subira Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vishal Khanna Director 08 Oct 2013 Current
Kavita Khanna Director 08 Oct 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Subira Pharmaceuticals.

Subira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.6% increase. The company also saw a substantial fall in profitability, with a 24.26% decrease in profit. The company's net worth Soared by an impressive increase of 21.12%.

Subira Pharmaceuticals revenue growth over time
Subira Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.60%
*******
*******
*******
*******
Revenue from Operations
*******
 16.24%
*******
*******
*******
*******
Total Assets
*******
 25.58%
*******
*******
*******
*******
Profit or Loss
*******
 -24.26%
*******
*******
*******
*******
Net Worth
*******
 21.12%
*******
*******
*******
*******
EBITDA
*******
 -35.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Subira Pharmaceuticals?

Unlock access to Subira Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,000,000.00

Satisfied Charges

₹22,073,390.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
30 Jan 2025 Hdfc Bank Limited ₹5.00 M Open
04 May 2022 Hdfc Bank Limited ₹2.50 M Satisfied
01 Dec 2020 Others ₹1.96 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Subira Pharmaceuticals?

Unlock and access historical data on people associated with Subira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Subira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subira Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Subira Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Subira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Subira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 101041149 was registered on 30 Jan 2025. was completed.

  • Charges

    Progress on A charge registered on 04 May 2022 via Charge ID 100571724 with Hdfc Bank Limited was fully satisfied on 22 Jan 2025. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100571724 was registered on 04 May 2022. was recorded as a recent event.

  • Charges

    A charge registered on 01 Dec 2020 via Charge ID 100401055 with Others was fully satisfied on 03 Feb 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Subira Pharmaceuticals Private Limited?

The CIN of Subira Pharmaceuticals Private Limited is U24233MH2013PTC328984.

Where is Subira Pharmaceuticals Private Limited headquartered?

Subira Pharmaceuticals Private Limited is headquartered at A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West, Mumbai, Maharashtra, 400053.

When was Subira Pharmaceuticals Private Limited incorporated?

Subira Pharmaceuticals Private Limited was incorporated on 08 October 2013.

Who are the current directors of Subira Pharmaceuticals Private Limited?

The current directors of Subira Pharmaceuticals Private Limited are

What is the primary industry of Subira Pharmaceuticals Private Limited?

The primary industry of Subira Pharmaceuticals Private Limited is Manufacturing.

Is Subira Pharmaceuticals Private Limited a listed company?

Subira Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Subira Pharmaceuticals Private Limited?

The authorized capital of Subira Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Subira Pharmaceuticals Private Limited?

The compliance status of Subira Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available